eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Pharma Mar, S.A.
Avda. de Los Reyes 1, Poligono Industrial La Mina, Colmenar Viejo, Madrid, 28770, Spain
Telephone: +44 (0)1932 824100
Fax: +44 (0)1932 842300
Medical Information Direct Line: +44 (0)1932 824026
Medical Information e-mail: mpenas@pharmamar.com
Customer Care direct line: +44 (0)1932 824100
Medical Information Fax: +44 (0)1932 824 226

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 08/02/2012
PIL Yondelis 0.25 mg powder for concentrate for solution for infusion/Yondelis 1 mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 01/06/2011 and displayed until 08/02/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 09/11/2009 and displayed until 01/06/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 29/07/2009 and displayed until 09/11/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/04/2009 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to Further Information section
Updated on 24/11/2008 and displayed until 30/04/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/12/2007 and displayed until 24/11/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  trabectedin